The US Bankruptcy Court gave an order approving the sale of substantially all the assets of PLx Pharma Inc. on May 25, 2023. The debtor has been authorized to sell substantially all its assets to PLx Acquisition Company, LLC for a purchase price consisting of credit bid in the amount of $3 million in cash plus $0.1 million in cash plus assumed liabilities. The buyer is represented by W. Benjamin Winger and Katie Allison of DLA Piper LLP (US) as it legal advisors.